
|Articles|September 27, 2006
Idenix Names Weidenbruch General Counsel
Author(s)BioPharm International Editors
Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel.
Advertisement
Idenix Pharmaceuticals, Inc. (Cambridge, MA,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
3
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
4
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
5




